About Askel Healthcare
Askel Healthcare is a company based in Helsinki (Finland) founded in 2017 by Anne Marie Haaparanta and Virpi Muhonen. Askel Healthcare offers products and services including COPLA® implant. Askel Healthcare operates in a competitive market with competitors including Kerecis, Kuros Biosciences, OssDsign, Sofregen and BONESUPPORT, among others.
- Headquarter Helsinki, Finland
- Founders Anne Marie Haaparanta, Virpi Muhonen
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Askel Healthcare Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$2.84 M (USD), Grant
Jan 01, 2022
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Askel Healthcare
Askel Healthcare offers a comprehensive portfolio of products and services, including COPLA® implant.
Biodegradable scaffold for repairing knee cartilage defects post-surgery.
People of Askel Healthcare
Unlock access to complete
Unlock access to complete
Funding Insights of Askel Healthcare
Investors in Askel Healthcare
Askel Healthcare has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Askel Healthcare
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Askel Healthcare
Investment portfolio details for Askel Healthcare
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Askel Healthcare
Detailed financials for Askel Healthcare
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Askel Healthcare Comparisons
Peer comparison for Askel Healthcare
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Askel Healthcare
Askel Healthcare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kerecis, Kuros Biosciences, OssDsign, Sofregen and BONESUPPORT, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Fish-skin acellular dermal matrix technology is provided for wound treatments.
|
|
| Locked | Locked | Locked |
Provider of smart solutions for bone disease management
|
|
| Locked | Locked | Locked |
Developer of regenerative 3D-printed orthopedic implants for craniofacial bone defects and trauma
|
|
| Locked | Locked | Locked |
Silk-derived biomaterials are developed for soft tissue repair in surgery.
|
|
| Locked | Locked | Locked |
Injectable synthetic bone substitutes are developed for fracture treatment.
|
|
| Locked | Locked | Locked |
Develops patented medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies
|
Detailed competitors of Askel Healthcare
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Askel Healthcare
Complete news archive for Askel Healthcare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Askel Healthcare
Askel Healthcare was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Askel Healthcare is headquartered in Helsinki, Finland.
Virpi Muhonen is the current CEO of Askel Healthcare. They have also founded this company.
Askel Healthcare was founded in 2017 in Helsinki, Finland, within the regenerative medicine sector. Focus is placed on developing therapies for cartilage and bone tissue repair. A COPLA scaffold, consisting of a 3D biodegradable structure, is utilized for cartilage regeneration in weight-bearing joints. Solutions for preventing osteoarthritis in veterinary applications are also provided, supporting tissue repair and joint health maintenance.
Askel Healthcare's top competitors include Kerecis, BONESUPPORT and OssDsign.
Askel Healthcare offers COPLA® implant.
Askel Healthcare has 2 investors. Key investors include European Union, and EIC Fund.